The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype.

The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype.

Item
http://www.wikidata.org/entity/Q33187483
ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate.Mesothelin, a possible target for immunotherapy, is expressed in primary AML cells.Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia.Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia.Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA.Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects.Chemotherapy curable malignancies and cancer stem cells: a biological review and hypothesisTransmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.Reversal of multidrug resistance by cisplatin-loaded magnetic Fe3O4 nanoparticles in A549/DDP lung cancer cells in vitro and in vivoABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer.Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis papermRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2.Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.A critical review on properties and applications of microbial l-asparaginases.Lipid-coated polymeric nanoparticles for cancer drug delivery.Effects of 3β-acethyl tormentic acid (3ATA) on ABCC proteins activity.ABCC4/MRP4: a MYCN-regulated transporter and potential therapeutic target in neuroblastoma.ATP Binding Cassette C1 (ABCC1/MRP1)-mediated drug efflux contributes to disease progression in T-lineage acute lymphoblastic leukemia.Expression and localization of ATP binding cassette (ABC) family of drug transporters in gastric hepatoid adenocarcinomas.Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: relation to long-term survival.Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms.
P2860
Q33281867-3CBF6DF6-C864-4DF7-89A6-4634B4576329Q33295383-0A8B0995-1ECF-4D2C-BB08-F802BDFE1323Q33297414-6174D5C6-66FC-4954-8F62-BC31FD073268Q33395469-B23A5514-A9A2-4ADC-B9B1-4C77B7E4655DQ33799305-0BE49F73-EB8C-4742-BDF3-F19D4A79D2A9Q33960952-8EF4B5BF-1EB9-4735-80B4-C16473884390Q34204238-A885ED79-8204-4E88-B689-9136CB4AEA13Q34634251-EDCDA451-16C1-44DF-B918-91890065CB43Q36200232-61200A8F-36B6-4E21-AE92-82FD50648EE2Q36525551-7607518D-9EE6-415E-BD6C-EAA802CA5952Q36851857-0369C935-092F-4FCE-8FB4-93E33DE81430Q37595188-F05981D3-20D3-43B0-987A-6CE83FD3CE43Q37608106-BCBC7F26-DB98-40BE-947F-3B1D9292E2CDQ37610090-10936D0C-F54D-4566-94C6-EC6412E7C88FQ38243832-2B61BE3A-F646-43E8-A35F-57A810F62054Q38417141-45B65533-504F-4684-8BEC-74CE47BD7DFFQ38556750-3F340915-E07F-4D17-BAC7-C322B079EC71Q39307419-9C90C34C-D53D-40BE-B73C-4A04FAF64F6AQ39498028-2AF65D6C-848B-4F15-A28D-872152798CA1Q42203233-0947265D-A179-4EFA-954D-0BAD6080BC86Q44956899-471EC265-3FDB-47F9-9E2E-1143376A2CD7Q46110606-CFC348F6-4F26-4446-AC5C-20A8658930EDQ47783708-AE68DBF4-FDD2-4B12-8935-169CEEA0B807Q48323019-35566BBF-AAAA-4AA7-BC81-9B223856AD02
P2860

The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype.

Item
http://www.wikidata.org/entity/Q33187483
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The multidrug resistance-assoc ...... ts and T-cell immunophenotype.
@ast
The multidrug resistance-assoc ...... ts and T-cell immunophenotype.
@en
type
label
The multidrug resistance-assoc ...... ts and T-cell immunophenotype.
@ast
The multidrug resistance-assoc ...... ts and T-cell immunophenotype.
@en
prefLabel
The multidrug resistance-assoc ...... ts and T-cell immunophenotype.
@ast
The multidrug resistance-assoc ...... ts and T-cell immunophenotype.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
The multidrug resistance-assoc ...... ts and T-cell immunophenotype.
@en
P2093
P304
P31
P356
10.1182/BLOOD-2002-11-3461
P407
P433
P478
P577
P698
P921